-
Personalised cell therapy developer Achilles closes £100m round
pharmaceutical-technology
September 05, 2019
UK-based Achilles Therapeutics has announced the closing of its £100m Series B financing round, which was led by new investor RA Capital Management and founding investor Syncona.
-
Warning issued to company for selling unapproved stem cell products
europeanpharmaceuticalreview
September 05, 2019
A warning has been issued to Stemell for manufacturing and distributing unapproved products derived from umbilical cord blood.
-
Study shows the potential to deliver immunotherapy directly to brain tumours
europeanpharmaceuticalreview
September 02, 2019
New nano-immunotherapy has traversed the blood-brain barrier in mice, inducing an immune response in brain tissue surrounding tumours.
-
Interactions discovered in cells insulating nerve pathways
worldpharmanews
August 29, 2019
Schwann cells form a protective sheath around nerve fibres and ensure that nerve impulses are transmitted rapidly.
-
Mustang Bio, CSL Behring Enter License Agreement for Stable Producer Cell Line
contractpharma
August 28, 2019
Cytegrity™ is a stable producer cell line developed by St. Jude Children’s Research Hospital for the treatment of X-linked severe combined immunodeficiency.
-
Preventing tumor metastasis
worldpharmanews
August 23, 2019
Researchers at the Paul Scherrer Institute, together with colleagues from the pharmaceutical company F. Hoffmann-La Roche AG...
-
Atelerix Consortium Awarded £267,000 Innovate UK Grant for Collaboration with the Cell and Gene Therapy Catapult and Rexgenero on Cell Therapy Stabilisation Technologies
b3cnewswire
August 22, 2019
Rexgenero, a regenerative medicine company pioneering the development of advanced cell-based therapies to treat chronic limb-threatening ischaemia (CLI)...
-
Sartorius Stedim Biotech Launches New Services for Mammalian Cell Bank Manufacturing
b3cnewswire
August 13, 2019
Sartorius Stedim Biotech (SSB), a leading partner of the biopharmaceutical industry, today announced the launch of new services for mammalian cell bank manufacture under GMP conditions.
-
Giant Cell Arteritis Occurs at Similar Rate in Blacks, Whites
drugs
August 12, 2019
Biopsy-proven giant cell arteritis (BP-GCA) occurs at a similar rate among white and black patients, according to a study published online in JAMA Ophthalmology.
-
Sartorius Launches New Services for Mammalian Cell Bank Manufacture
contractpharma
August 09, 2019
Combines services for cell line development, cell bank manufacturing, and cell bank characterization.